Researchers have identified a potential genetic target for treating an especially painful and invasive form of endometriosis.

Researchers have completed a clinical trial suggesting that the antidepressant drug fluvoxamine may help prevent deterioration in COVID-19 […]

Johnson & Johnson confident in 1B dose goal for COVID vaccine next year, looking ahead to 2022 fkansteiner […]

AstraZeneca’s Calquence fails COVID-19 study, joining the list of repurposed meds that have fallen short esagonowsky Thu, 11/12/2020 […]

Generics players join pledge to rapidly scale access to COVID-19 drugs. But will pharma sign on? kblankenship Thu, […]

COVID antibody drugs from Lilly and Regeneron won’t do much to boost their top lines: analysts arlene.weintraub Thu, […]

Even with decades of unprecedented development in computational power, the human brain still holds many advantages over modern […]

UC San Francisco scientists have developed a single clinical laboratory test capable of zeroing in on the microbial […]

JADE REGIMEN study investigated JAK1 inhibitor in moderate to severe atopic dermatitis

Study will collect real-world data on use of INOmax in COVID-19 patients